Epidermolysis Bullosa Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex
Condition: Epidermolysis Bullosa Simplex Interventions: Drug: TolaSure Topical Gel; Drug: Vehicle Topical Gel Sponsor: BioMendics, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 30, 2021 Category: Research Source Type: clinical trials
